Weight loss has become the single fastest-growing service category in the med spa industry. The arrival of GLP-1 receptor agonist medications — semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) — has fundamentally transformed the weight management market. Patients who previously cycled through fad diets and unsupervised supplement regimens now have access to medications that produce 15-22% average body weight loss, and they are actively seeking medical providers to prescribe and monitor these treatments.
For med spa owners, this represents a once-in-a-decade revenue opportunity. Med spa weight loss programs combine high-margin medication management with recurring monthly revenue, natural cross-sells into body contouring and wellness services, and patient relationships that last years rather than single appointments. The practices that move decisively to build structured weight loss programs are capturing a patient population that generates $5,000-$15,000 in lifetime value per client — multiples higher than traditional aesthetic patients.
Yet building a weight loss program requires more than adding semaglutide to your service menu. The practices generating $500K-$1M+ annually from weight management have built comprehensive programs with structured protocols, compliance-driven medical oversight, strategic pricing, and complementary service ecosystems that maximize both clinical outcomes and revenue per patient.
Key Insight: The global weight loss market is projected to exceed $200 billion by 2028, with GLP-1 medications driving the fastest segment of growth. Med spas managing 150 active weight loss patients at an average program fee of $500/month generate $900,000 in annual recurring revenue — before body contouring, supplements, and IV therapy add-ons.
1. Why Weight Loss Is the Fastest-Growing Med Spa Category
Understanding the market forces behind the weight loss boom helps you position your program for long-term growth rather than chasing a trend.
The GLP-1 Revolution
GLP-1 receptor agonists have changed the weight loss conversation from willpower-based dieting to evidence-based medical treatment. The clinical data is strong:
- Semaglutide 2.4mg (Wegovy): Average weight loss of 15-17% of body weight over 68 weeks in the STEP trial program. Patients lost an average of 35 pounds, with some losing 50+ pounds.
- Tirzepatide (Zepbound): Average weight loss of 20-22% of body weight in the SURMOUNT trials — roughly 50-55 pounds for a 250-pound patient. This dual GIP/GLP-1 agonist has shown the strongest weight loss results of any approved medication.
- Patient demand: Google searches for "semaglutide near me" and "GLP-1 weight loss" have increased over 400% since 2023. Patients are actively seeking providers, and many are willing to pay out-of-pocket for faster access than insurance-based prescribing allows.
Why Med Spas Are Ideally Positioned
Med spas occupy a unique position in the weight loss market that primary care practices and weight loss clinics cannot easily replicate:
- Cash-pay model: Most insurance plans still restrict GLP-1 coverage or require extensive prior authorizations. Med spa patients are already accustomed to paying out-of-pocket for elective medical services, eliminating the insurance friction that frustrates both patients and providers.
- Aesthetic integration: Weight loss patients naturally need body contouring services as they lose volume. Loose skin, stubborn fat pockets, and body shape concerns create organic demand for CoolSculpting, Emsculpt, and skin tightening — services you may already offer.
- Wellness positioning: Med spas are perceived as health-focused, lifestyle-oriented environments rather than clinical disease-management settings. This appeals to weight loss patients who want to feel empowered rather than pathologized.
- Concierge experience: Longer appointment times, personalized attention, and boutique environments differentiate med spa weight loss programs from the 5-minute primary care visit with a prescription.
Market Reality: Over 42% of American adults have obesity (BMI 30+), and another 30% are overweight. With GLP-1 medications making medical weight loss achievable for the first time, the addressable market for med spa weight management programs is enormous — and still in its earliest growth phase.
2. Revenue Potential: $500K to $1M+ Annually
Weight loss programs generate revenue through multiple streams, creating a diversified and resilient business model that compounds over time.
Primary Revenue: Medication Management
The core of your weight loss revenue comes from monthly medication management fees that cover the GLP-1 prescription, medication supply (if using compounded formulations), and ongoing clinical monitoring:
- Semaglutide programs: $350-$500/month including compounded medication, weekly injection or pen supply, and monthly provider check-in. Medication cost (compounded): $80-$150/month. Gross margin: 55-70%.
- Tirzepatide programs: $450-$650/month including compounded medication and monitoring. Medication cost (compounded): $120-$200/month. Gross margin: 50-65%.
- Brand-name programs: If dispensing brand-name Wegovy or Zepbound, pricing runs $1,200-$1,600/month at retail. Some practices use buy-and-bill models with specialty pharmacies, generating 15-25% margins on the medication plus separate consultation fees.
Revenue Projection Model
Here is a conservative revenue model for a med spa weight loss program in its first 18 months:
- Months 1-6 (ramp-up): Grow from 20 to 75 active patients. Average monthly revenue: $25,000-$37,500. Cumulative: $187,500.
- Months 7-12 (growth): Grow from 75 to 150 active patients. Average monthly revenue: $56,000-$75,000. Cumulative: $393,000.
- Months 13-18 (maturity): Maintain 150-200 active patients with referral-driven growth. Average monthly revenue: $75,000-$100,000. Cumulative: $525,000.
- Year 2 annual run rate: $900,000-$1,200,000 from medication management alone.
Secondary Revenue Streams
The full revenue impact of a weight loss program extends well beyond medication management:
- Body contouring services: 40-60% of weight loss patients purchase body contouring treatments during or after their program. Average spend: $3,000-$6,000 per patient. For 150 patients, this adds $180,000-$540,000 annually.
- IV therapy and vitamin injections: B12, lipotropic (MIC), and vitamin D injections are popular add-ons. Revenue: $50-$150 per session, 2-4 times per month. Adds $30,000-$80,000 annually for 150 patients.
- Nutritional supplements: Medical-grade supplements (protein powders, probiotics, multivitamins) at 50-60% margins. Average: $75-$150/month per patient. Adds $50,000-$100,000 annually.
- Consultation and lab fees: Initial consultation ($150-$300), body composition analysis ($50-$100), and periodic lab work ($100-$200) generate $30,000-$60,000 annually.
Build Your Weight Loss Revenue Engine
RunMedSpa manages patient programs, tracks medication protocols, automates refill reminders, and monitors body composition progress — so you can scale to 200+ weight loss patients without drowning in admin work.
Join the Waitlist3. Program Structure: From Consultation to Maintenance
The most profitable weight loss program med spa practices build structured multi-phase programs rather than open-ended prescriptions. Structure improves clinical outcomes, justifies premium pricing, and creates natural upsell opportunities at each phase transition.
Phase 1: Initial Consultation and Assessment (Week 0)
The initial consultation sets the clinical foundation and establishes the patient relationship. Charge $200-$350 for a comprehensive assessment that includes:
- Medical history review: Screen for contraindications including personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, gastroparesis, and gallbladder disease.
- Body composition analysis: Use a bioimpedance device (InBody, Tanita) to measure body fat percentage, lean muscle mass, visceral fat level, and basal metabolic rate. Cost: $3,000-$8,000 for the device; $0 per scan thereafter.
- Baseline labs: CBC, CMP, lipid panel, HbA1c, thyroid panel, fasting insulin. Partner with a lab service or offer in-house draws at markup. Lab cost: $30-$80; charge: $150-$250.
- Goal setting and program selection: Present your tiered program options (12-week, 6-month, maintenance) with clear pricing, expected timelines, and outcome benchmarks.
- Before photos: Standardized photos from multiple angles. These become powerful marketing assets (with consent) and motivational tools for the patient.
Phase 2: Active Weight Loss (Weeks 1-12)
The initial 12-week program is the core treatment phase where patients see the most dramatic results. Structure biweekly or monthly touchpoints:
- GLP-1 titration: Start semaglutide at 0.25mg weekly for 4 weeks, then 0.5mg for 4 weeks, then 1.0mg for 4 weeks, then 1.7mg and 2.4mg as tolerated. Tirzepatide: 2.5mg for 4 weeks, 5mg for 4 weeks, then increase by 2.5mg every 4 weeks up to 15mg as needed.
- Biweekly check-ins (15-20 minutes): Weight, body composition scan, side effect management, medication adjustment, and nutritional coaching. These can be in-person or telehealth to reduce no-shows.
- Nutrition coaching: Provide structured meal guidance emphasizing protein intake (critical to preserve lean mass on GLP-1 therapy). Many practices offer group nutrition sessions (4-8 patients) to deliver coaching efficiently at $50-$75 per session.
- Side effect management: Nausea, constipation, and injection site reactions are common in early weeks. Proactive management (anti-nausea protocols, hydration guidance, fiber supplementation) dramatically improves retention.
Phase 3: Extended Weight Loss (Months 4-6)
Patients who complete the initial 12 weeks typically transition to an extended program with monthly touchpoints:
- Monthly provider visits: Weight, body composition, medication management, and progress photos. 15-20 minutes per visit.
- Dose optimization: By month 4-6, most patients are on their maintenance dose. Some may need dose adjustments based on side effects, weight loss plateau, or budget considerations.
- Body contouring introduction: As patients approach their goal weight, introduce body contouring consultations for residual fat pockets and skin laxity. This is the natural cross-sell point where 40-60% of patients add services.
- Lab reassessment: Repeat baseline labs at the 6-month mark to document metabolic improvements (often dramatic: HbA1c reductions, improved lipid panels, reduced insulin resistance). These results reinforce the value of the program.
Phase 4: Maintenance (Month 7+)
Maintenance is where the long-term recurring revenue lives. Current evidence suggests most patients need ongoing GLP-1 therapy to maintain weight loss, which creates a sustainable revenue stream:
- Reduced-dose maintenance: Some patients can maintain weight loss on lower GLP-1 doses, reducing medication cost while maintaining the monthly program fee.
- Quarterly visits: Transition to quarterly in-person visits with telemedicine check-ins between appointments. This reduces provider time while maintaining the patient relationship.
- Annual program renewals: Offer annual maintenance program packages at a slight discount to month-to-month pricing. A $400/month program offered as an annual package at $4,200 ($350/month) locks in 12 months of revenue.
- Ongoing body composition tracking: Quarterly scans to make sure maintenance of lean mass and monitor for weight regain. These data points reinforce the need for continued treatment.
4. GLP-1 Medication Protocols and Pricing Strategy
Your medication sourcing and pricing strategy directly impacts margins, compliance risk, and competitive positioning. There are three primary models for GLP-1 med spa programs.
Model 1: Compounded Semaglutide and Tirzepatide
Compounded formulations from 503A or 503B pharmacies offer the most favorable economics for med spas:
- Cost per month: Semaglutide $40-$100; Tirzepatide $60-$150 (varies by dose and pharmacy)
- Patient price: $300-$500/month (semaglutide); $400-$600/month (tirzepatide)
- Gross margin: 60-75%
- Advantages: Highest margins, ability to customize dosing, price competitiveness versus brand-name alternatives
- Risks: FDA regulatory environment is evolving — compounding is currently permitted when brand-name products are on the FDA shortage list. Monitor shortage status and have contingency plans.
- Compliance: Use only FDA-registered 503A (patient-specific) or 503B (outsourcing facility) pharmacies. Verify sterility testing, potency verification, and beyond-use dating.
Model 2: Brand-Name Prescriptions
Prescribing brand-name Wegovy or Zepbound through retail or specialty pharmacies:
- Patient cost: $1,000-$1,600/month without insurance
- Your revenue model: Monthly program fee ($200-$400) covering consultations, monitoring, and coaching — separate from the medication cost the patient pays at the pharmacy
- Gross margin on program fee: 80-90% (no medication cost)
- Advantages: No medication liability, no compounding risk, insurance may cover for some patients
- Disadvantages: Higher total cost to patient limits your addressable market; you lose the medication margin
Model 3: Hybrid Approach
The most successful semaglutide med spa programs offer both options, allowing patients to choose based on budget and preference:
- Premium tier: Brand-name medication + concierge program with weekly check-ins, nutrition coaching, supplement bundle. $800-$1,200/month total.
- Standard tier: Compounded medication + biweekly monitoring and group nutrition sessions. $400-$550/month total.
- Core tier: Compounded medication + monthly check-in. $300-$400/month. Designed for price-sensitive patients and high-volume scaling.
Pricing Benchmark: Market research across 200+ med spas offering GLP-1 programs shows the median monthly program fee (including compounded medication) is $450/month for semaglutide and $550/month for tirzepatide. Practices in affluent markets charge 20-40% above these figures; competitive markets run 10-20% below. Price your program based on your local market, service level, and positioning.
5. Complementary Services: Body Contouring, IV Therapy, and Supplements
Weight loss patients generate significantly more revenue when you build a service ecosystem around their journey. Each phase of weight loss creates natural demand for complementary treatments.
Body Contouring: The Natural Cross-Sell
As patients lose weight, stubborn fat deposits and skin changes create demand for body sculpting. The most common add-ons:
- CoolSculpting (cryolipolysis): $750-$1,500 per applicator, 2-4 applicators per area, 1-2 treatment cycles. Average patient spend: $3,000-$6,000. Best for patients with localized fat deposits that persist despite significant weight loss.
- Emsculpt NEO: $750-$1,000 per session, 4-session protocol recommended. Average patient spend: $3,000-$4,000. Uniquely valuable for weight loss patients because it simultaneously reduces fat and builds muscle — addressing the lean mass preservation concern inherent in GLP-1 therapy.
- Radiofrequency skin tightening (Morpheus8, Thermage): $1,000-$3,000 per treatment area, 1-3 sessions. Addresses skin laxity that develops during significant weight loss.
- Laser lipolysis (SculpSure): $1,500-$2,500 per area, non-invasive alternative to CoolSculpting with shorter treatment times.
IV Therapy and Injections
Vitamin and nutrient therapies complement weight loss programs with high margins and fast treatment times:
- B12 injections: $25-$50 per injection, weekly or biweekly. Cost: $2-$5. Supports energy levels during caloric restriction. Offer as an included perk or add-on.
- Lipotropic (MIC) injections: $35-$75 per injection, weekly. Methionine, inositol, and choline support fat metabolism. Popular add-on with perceived weight loss support.
- IV hydration and vitamin drips: $150-$300 per session. "Weight Loss Boost" IV formulas with B-complex, amino acids, and L-carnitine. 30-45 minutes per session, 85%+ margins.
- Vitamin D supplementation: Deficiency is common in obese patients. Offer high-dose monthly injections ($50-$75) or oral supplementation.
Nutritional Supplements
Medical-grade supplements are a high-margin, recurring revenue stream that supports clinical outcomes:
- Protein supplements: GLP-1 patients need 80-120g protein daily to preserve lean mass. Offer branded protein powders at $40-$60/month with 50-60% margins.
- Probiotics: GI side effects are common with GLP-1 therapy. Medical-grade probiotics at $30-$50/month support GI health and represent a genuine clinical need.
- Fiber supplements: Address constipation (a top GLP-1 side effect) with premium fiber products at $20-$35/month.
- Multivitamins and omega-3s: Bundle essential supplements into a "Weight Loss Essentials Kit" at $75-$120/month for convenience and compliance.
6. Marketing Strategies for Weight Loss Programs
Weight loss marketing for med spas must balance aggressive patient acquisition with regulatory compliance and brand positioning. The practices generating the highest patient volume use multi-channel strategies anchored in education and social proof.
Search Engine Optimization (SEO)
Weight loss keywords have enormous search volume and moderate competition. Prioritize these pages and content:
- Service page: Dedicated "Medical Weight Loss" or "GLP-1 Weight Loss Program" page optimized for "[your city] medical weight loss" and "semaglutide near me." Include program details, pricing transparency, provider credentials, and clear CTAs.
- Blog content: Publish educational articles targeting questions patients search: "semaglutide vs tirzepatide," "GLP-1 side effects," "how much weight can you lose on semaglutide," "cost of medical weight loss." Each article drives organic traffic and builds topical authority.
- Local SEO: Optimize your Google Business Profile for weight loss keywords. Request reviews specifically mentioning weight loss results. Post weekly updates about your weight loss program.
Social Media and Content Marketing
Weight loss transformations are among the most shareable content in the aesthetic space:
- Patient transformation stories: Before-and-after photos with patient testimonials (with proper consent and HIPAA compliance) generate massive engagement and referrals. Video testimonials are even more powerful.
- Educational Reels and TikToks: Short-form videos explaining GLP-1 mechanisms, debunking myths, and answering common questions position your providers as trusted experts. Topics like "What your doctor won't tell you about semaglutide" and "5 mistakes people make on GLP-1 medications" consistently drive views.
- Provider authority content: Your prescribing provider explaining treatment protocols, sharing clinical knowledge, and discussing patient cases (de-identified) builds trust and differentiates from online-only telehealth prescribers.
Paid Advertising
Paid channels can accelerate patient acquisition once your program is operational:
- Google Ads: Target "semaglutide [city]," "medical weight loss near me," and "GLP-1 weight loss program." Expect $15-$40 cost per click and $100-$300 cost per lead. With average patient lifetime value of $5,000-$10,000, even expensive leads are profitable.
- Meta (Facebook/Instagram) Ads: Use transformation stories and educational content as ad creative. Compliance note: avoid before-and-after claims that could violate platform advertising policies. Focus on educational messaging and consultation offers.
- Referral programs: Offer $100-$200 credit to existing patients who refer new weight loss patients. Referral leads convert at 2-3x the rate of cold advertising leads and have higher retention.
Acquisition Cost Benchmark: Successful med spa weight loss programs report patient acquisition costs of $150-$400 per new patient. With average 8-12 month patient retention and $400-$600 monthly program revenue, the return on marketing investment typically exceeds 10:1 within the first year of each patient relationship.
7. Compliance Considerations: Prescribing Authority and Medical Oversight
Weight loss programs carry more regulatory complexity than most med spa services. Building compliance into your program from day one protects your practice and patients.
Prescribing Authority
GLP-1 medications are prescription-only, requiring a licensed prescriber at the center of your program:
- Physician-led model: An MD or DO serves as both medical director and primary prescriber. Most strong from a regulatory standpoint. Required in states with restrictive scope-of-practice laws.
- NP/PA collaborative model: Nurse practitioners or physician assistants prescribe under a collaborative practice agreement with your medical director. Common in states with moderate scope-of-practice laws. Allows scaling to multiple providers more cost-effectively.
- Independent NP model: In full-practice-authority states (approximately 26 states), NPs can prescribe independently. Simplifies the operational model but still requires clinical protocols and quality oversight.
Medical Director Responsibilities
Your medical director should establish and oversee the following for your weight loss program:
- Treatment protocols: Written protocols covering patient screening criteria, contraindication lists, dosing schedules, titration guidelines, side effect management, and emergency procedures
- Patient screening standards: BMI thresholds (typically 27+ with comorbidity or 30+), required baseline labs, medical history red flags, and psychiatric screening for eating disorders
- Pharmacy compliance: Verification that compounding pharmacies are properly licensed (503A or 503B), with current sterility and potency testing documentation
- Adverse event protocols: Clear procedures for managing side effects, drug interactions, and medical emergencies including pancreatitis, gallbladder events, and severe GI complications
- Chart review: Regular review of patient charts to make sure protocol adherence and clinical quality
Advertising Compliance
Weight loss advertising is among the most heavily scrutinized categories. Follow these guidelines:
- Never guarantee specific weight loss results. Use language like "patients may experience" or "average results in clinical studies."
- Do not use brand names (Ozempic, Wegovy, Mounjaro) in advertising without explicit authorization. Instead, reference the generic drug names (semaglutide, tirzepatide) or the drug class (GLP-1 receptor agonists).
- Include appropriate disclaimers: "Results may vary. Requires medical evaluation. Not appropriate for all patients."
- Make sure before-and-after photos comply with both state medical board guidelines and advertising platform policies.
8. Patient Retention Through Structured Programs
The difference between a $300,000 weight loss program and a $1,000,000 weight loss program is retention. Patients who stay in your program for 12+ months generate 4-6x the lifetime value of patients who drop off after the initial prescription.
The 12-Week Foundation Program
Design your initial program as a 12-week commitment with clear milestones:
- Week 1: Full assessment, baseline labs, body composition, medication initiation, and nutrition plan
- Week 2: Side effect check-in (phone or telehealth, 10 minutes). Address nausea, appetite changes, injection technique
- Week 4: In-person visit with body composition scan, dose titration, progress review
- Week 8: In-person visit with body composition scan, progress photos, dose optimization, body contouring consultation if appropriate
- Week 12: Comprehensive review with body composition, progress photos, lab reassessment, and transition to 6-month extended program
Price the 12-week program as a package ($1,800-$3,000 including medication) rather than month-to-month. Package pricing commits patients through the critical early period when side effects are most likely to cause dropout.
The 6-Month Extended Program
After 12 weeks, transition patients to a 6-month extended program with monthly touchpoints:
- Monthly in-person visits (20 minutes): weight, body composition, medication management, progress photos
- Monthly group nutrition sessions (optional, 45-60 minutes): community building, education, and accountability
- Quarterly lab reassessment to document metabolic improvements
- Body contouring treatments scheduled during months 4-6 as patients approach goal weight
- Price: $400-$600/month including medication, or $2,100-$3,200 per 6-month package
The Maintenance Program
Maintenance patients require the least provider time but generate the most predictable revenue:
- Quarterly in-person visits with body composition tracking
- Monthly telehealth check-ins (10 minutes) or asynchronous messaging
- Continued medication management (often at reduced doses)
- Annual comprehensive reassessment with labs and body composition
- Price: $300-$450/month including medication, or $3,200-$4,800 annually
Retention Strategies That Work
Practices with the highest weight loss patient retention (18+ month average) use these strategies:
- Community building: Private Facebook groups, group coaching sessions, or in-person patient events create accountability and social connection that medication alone cannot provide.
- Milestone celebrations: Recognize 10%, 15%, and 20% body weight milestones with certificates, small gifts, or complimentary services. These moments create emotional anchoring to your practice.
- Progress visualization: Show patients their body composition trends over time — fat mass decreasing, lean mass preserved, visceral fat dropping. Data-driven progress is more motivating than scale weight alone.
- Automated communication: Scheduled SMS and email touchpoints between visits: medication reminders, hydration and protein tips, and motivational messages. Automation maintains engagement without consuming provider time.
Retention Impact: Med spas with structured multi-phase programs report average patient retention of 9-14 months, compared to 3-5 months for practices that offer GLP-1 prescriptions without program structure. This 3x retention difference translates directly to 3x lifetime revenue per patient.
9. Operational Considerations for Scaling
As your weight loss program grows beyond 50 patients, operational systems become critical. The practices that scale to 200+ patients without quality degradation invest in these systems early:
- EMR integration: Use an EMR that supports weight management workflows — body composition tracking, medication titration logging, lab result integration, and automated follow-up scheduling.
- Medication inventory management: Track compounded medication inventory, expiration dates, and reorder points. Running out of medication destroys patient trust and causes churn.
- Provider capacity planning: One full-time provider (NP or PA) can manage 80-120 active weight loss patients with proper scheduling. Plan hiring 8-12 weeks before you expect to hit capacity.
- Patient communication automation: Automated appointment reminders, medication refill notifications, progress check-ins, and educational content sequences reduce manual staff workload by 60-70%.
- Financial tracking: Track revenue, medication COGS, provider labor, and marketing cost per patient separately for your weight loss program. This data informs pricing adjustments, marketing allocation, and staffing decisions.
Frequently Asked Questions
How much can a med spa earn from a weight loss program?
A well-structured med spa weight loss program can generate $500,000 to $1,000,000+ in annual revenue. GLP-1 medication management alone generates $400-$600 per patient per month, with margins of 50-65% on compounded formulations. A practice managing 100 active patients at $500/month produces $600,000 annually from medication management alone. Add body contouring ($2,000-$6,000 per patient), IV therapy, supplements, and maintenance programs, and total revenue frequently exceeds $1 million for established practices.
Do you need a medical director to offer GLP-1 medications at a med spa?
Yes. GLP-1 medications like semaglutide and tirzepatide are prescription medications requiring a licensed prescriber — either a physician, nurse practitioner, or physician assistant depending on your state's scope-of-practice laws. Most med spas operate under a medical director (MD or DO) who establishes treatment protocols, oversees prescribing, and provides clinical supervision. Your medical director should establish standing orders, dosing protocols, patient screening criteria, and emergency procedures before launching.
What is the best GLP-1 medication for med spa weight loss programs?
Both semaglutide and tirzepatide are effective. Semaglutide produces average weight loss of 15-17% of body weight with extensive clinical data. Tirzepatide, a dual GIP/GLP-1 agonist, produces 20-22% average weight loss and has shown superior results in head-to-head studies. Most successful med spas offer both: semaglutide as a cost-effective option ($300-$450/month compounded) and tirzepatide as a premium option ($450-$600/month) for patients seeking maximum results.
Weight Loss Is the Med Spa Revenue Opportunity of the Decade
The convergence of clinically proven GLP-1 medications, massive consumer demand, and the med spa industry's existing cash-pay infrastructure creates a revenue opportunity that will define the next era of aesthetic medicine. Practices that build comprehensive med spa weight loss programs — with structured protocols, strategic pricing, complementary service ecosystems, and retention-focused patient journeys — are positioned to generate $500,000 to $1,000,000+ in annual revenue from a single program category.
The window for early-mover advantage is narrowing. As more practices add weight loss to their service menu, the competitive market will shift from "Do you offer GLP-1 weight loss?" to "How is your weight loss program better?" The practices winning that comparison will be those with the most structured programs, the best clinical outcomes, and the most strong patient experience. Start building your program today — the patients are already searching for you.
Ready to Launch Your Weight Loss Program?
RunMedSpa automates patient onboarding, medication tracking, body composition monitoring, and retention communication — everything you need to scale a profitable weight loss program without the operational complexity.
Join the Waitlist Today